Invasive Fungal Infection Clinical Trial
Official title:
PK-PD of Caspofungin (Cancidas ®) and Drug Tolerance of Fungi to Patients With an Invasive Fungal Infection in the Intensive Care Unit
To investigate pharmacokinetics(PK) and pharmacodynamics(PD) of Caspofungin in ICU patients after received a loading dose of 70mg followed by 50mg (35mg if Child-Pugh score is 7-9), 40 patients will be recruited. Blood samplings for PK analysis will be collected on day 4 in this study. Caspofungin plasma concentrations are measured by using solid phase extraction and reverse phase high-performance liquid chromatography. Safety analyses will be taken daily during the treatment of Caspofungin. Tests for drug tolerance of fungi and efficacy assessment (clinical and mycological responses) will be taken every 3 days by clinical and mycological tests.
n/a
Allocation: Non-Randomized, Endpoint Classification: Pharmacokinetics/Dynamics Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01888458 -
Antifungal Prophylaxis With Micafungin After Cord Blood Allogeneic Stem Cell Transplantation (MycaCOORD)
|
Phase 2 | |
Completed |
NCT00412893 -
Isavuconazole (BAL8557) for Primary Treatment of Invasive Aspergillosis
|
Phase 3 | |
Completed |
NCT03066011 -
Registry of Patients Treated With Systemic Mold-Active Triazoles
|
||
Completed |
NCT04004078 -
An Individualized Administration Research of Voriconazole Based on CYP2C19 Gene Polymorphism and TDM
|
||
Completed |
NCT01576653 -
Prospective Clinical Evaluation of Beta-D-Glucan Assay in Blood and BAL
|
N/A | |
Completed |
NCT01198236 -
Efficacy of Itraconazole as Secondary Prophylaxis in Patients Undergoing Allogeneic Stem Cell Transplantation or Chemotherapy With Prior Invasive Fungal Infection
|
Phase 4 | |
Recruiting |
NCT06137690 -
Factors on Therapeutic Drug Monitoring and Safety of Voriconazole in Critically Ill Elderly Patients
|
||
Completed |
NCT01783379 -
Pharmacokinetics of Micafungin in Patients Intensive Care Unit
|
||
Completed |
NCT01533558 -
Pharmacokinetics of Caspofungin (Cancidas ®) Given Intravenously as Therapy to Patients With an Invasive Fungal Infection in the Intensive Care Unit - a Search for Co-variates
|
||
Recruiting |
NCT03149562 -
Association of Plasma Transfusions and Invasive Fungal Infection
|
||
Recruiting |
NCT04665037 -
Posaconazole (MK-5592) Intravenous and Oral in Children (<2 Years) With Invasive Fungal Infection (MK-5592-127)
|
Phase 2 | |
Withdrawn |
NCT01185405 -
Voriconazole Plasma Level in Intensive Care Unit (ICU) Patients
|
N/A | |
Terminated |
NCT01148160 -
Voriconazole Trough Plasma Levels : Genetic Polymorphism, Efficacy, Safety in Patients With Hematologic Malignancy
|
N/A | |
Completed |
NCT00893555 -
Pharmacologic Optimization of Voriconazole
|
Phase 3 | |
Unknown status |
NCT00460330 -
Evaluate Three Methods for Diagnosis of Invasive Fungal Infection in Chinese Patients After HSCT
|
N/A | |
Completed |
NCT02823132 -
Study of the Level of a Protein Which Could Predict the Development of a Fungal Infection in Patients With Acute Leukemia
|
N/A |